OTUD5 Gene

📖 Wiki Page

gene934 wordssynced 2026-04-02

OTUD5 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">OTUD5 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>OTUD5</td>
</tr>
<tr>
<td class="label">Official Name</td>
<td>OTU Deubiquitinase 5</td>
</tr>
<tr>
<td class="label">Previous Symbols</td>
<td>SARS, DEXR1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>Chromosome Xp11.23</td>
</tr>
<tr>
<td class="label"> genomic coordinates</td>
<td>X: 48,934,288-48,971,633</td>
</tr>
<tr>
<td class="label">Strand</td>
<td>Positive strand</td>
</tr>
<tr>
<td class="label">Exon Count</td>
<td>7 exons</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>446 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~48 kDa</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Pathway</td>
</tr>
<tr>
<td class="label">PINK1</td>
<td>Mitophagy initiation</td>
</tr>
<tr>
<td class="label">Parkin</td>
<td>Ubiquitin ligase</td>
</tr>
<tr>
<td class="label">USP30</td>
<td>Mitophagy regulation</td>
</tr>
<tr>
<td class="label">α-Synuclein</td>
<td>Protein aggregation</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ischemia" style="color:#ef9a9a">Ischemia</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/neurodegeneration" style="color:#ef9a9a">Neurodegeneration</a>

...

OTUD5 Gene

Overview

OTUD5 (OTU Deubiquitinase 5) is a member of the ovarian tumor (OTU) family of deubiquitinating enzymes that catalyzes the removal of ubiquitin from target proteins. Also known as Deverrin or SARS, the OTUD5 gene encodes a cysteine protease that plays critical roles in protein quality control, autophagy, and cellular stress responses. Recent research has identified OTUD5 as a significant player in neurodegeneration, particularly in Parkinson's disease (PD), where it regulates alpha-synuclein degradation and protects dopaminergic neurons. PMID: 39721018

Gene Location and Structure

Genomic Information

Protein Domain Structure

The OTUD5 protein contains several functional domains:

OTU Domain (Ovarian Tumor): The catalytic domain (residues 160-380) contains the active site cysteine residue (Cys224) that mediates deubiquitinase activity

N-terminal Domain: Involved in protein-protein interactions

C-terminal Extension: Contains regulatory elements

Deubiquitinase Function

Enzymatic Activity

OTUD5 is a member of the CA clan of cysteine proteases, specifically the OTU subfamily. The enzyme catalyzes the hydrolysis of isopeptide bonds between ubiquitin and target proteins through a catalytic triad mechanism: PMID: 19354277

Catalytic Residues: Cys224, His372, Asp390
Substrate Specificity: Prefers K48-linked polyubiquitin chains but can hydrolyze K63-linked chains
Activity Regulation: Phosphorylation status and cellular localization modulate OTUD5 activity

Cellular Functions

OTUD5 participates in several critical cellular processes:

Protein Quality Control:

Removal of ubiquitin from misfolded or damaged proteins
Regulation of proteasomal degradation pathways
Coordination with autophagy-lysosomal pathways

Autophagy Regulation:

Modulation of autophagosome formation
Regulation of selective autophagy receptors
Control of mitophagy through Parkin-dependent pathways PMID: 19276523

DNA Damage Response:

Involvement in cellular stress response
Regulation of transcription factors

Role in Parkinson's Disease

PARK15 Locus Association

The OTUD5 gene localizes to the PARK15 locus on chromosome Xp11.23, which has been linked to familial Parkinson's disease. Mutations or variants in OTUD5 may contribute to PD susceptibility through: PMID: 19354278

Dysregulation of protein quality control mechanisms
Impaired clearance of neurotoxic proteins
Increased vulnerability of dopaminergic neurons

Alpha-Synuclein Degradation

The most significant finding regarding OTUD5 in neurodegeneration comes from recent research demonstrating its critical role in regulating alpha-synuclein (α-syn) degradation: PMID: 39721018

Key Findings:

OTUD5 Knockout: Mouse models with OTUD5 knockout develop severe alpha-synuclein pathology
Deubiquitination Role: OTUD5 removes K63-linked ubiquitin chains from alpha-synuclein, facilitating its autophagic clearance
Protective Function: Overexpression of OTUD5 protects dopaminergic neurons from α-syn-induced toxicity
Therapeutic Potential: OTUD5 activation may represent a novel therapeutic strategy for PD

Mechanistic Pathway

Mermaid diagram (expand to render)

Relationship to Other PD Genes

Interaction with Parkin and PINK1

OTUD5 function intersects with the well-characterized PARK2 (Parkin) and PARK6 (PINK1) mitophagy pathway: PMID: 19276523

All three proteins participate in mitochondrial quality control
OTUD5 may regulate ubiquitination of mitophagy receptors
Coordination between OTUD5 and Parkin ensures proper clearance of damaged mitochondria

Network Analysis

Therapeutic Targeting

Drug Development Opportunities

OTUD5 represents a promising therapeutic target for Parkinson's disease:

Small Molecule Activators:

Development of OTUD5 agonists to enhance α-syn clearance
Phytochemical screening for natural activators
Structure-based drug design targeting the OTU domain

Gene Therapy Approaches:

AAV-mediated OTUD5 overexpression
CRISPR-based OTUD5 activation
Antisense oligonucleotides targeting OTUD5 regulators

Combination Strategies:

OTUD5 activation + autophagy enhancers
OTUD5 + Parkin pathway modulators
OTUD5 + α-syn aggregation inhibitors

Challenges

Selectivity: Ensuring specific activation without affecting other deubiquitinases
Brain Delivery: Achieving adequate CNS penetration
Timing: Optimal intervention window in disease progression

Animal Models

Knockout Studies

Mouse models with OTUD5 knockout demonstrate:

Severe alpha-synuclein pathology in substantia nigra
Progressive dopaminergic neuron loss
Motor coordination deficits
Shortened lifespan

Transgenic Models

Overexpression models show:

Protection against α-syn-induced neurodegeneration
Improved motor performance
Normal ubiquitin-proteasome system function

Clinical Relevance

Genetic Studies

OTUD5 variants have been identified in PD patient cohorts
X-linked inheritance pattern in some families
Variable penetrance suggests environmental modifiers

Biomarker Potential

OTUD5 expression levels in peripheral blood mononuclear cells (PBMCs) may serve as:

Disease progression marker
Therapeutic response indicator
Preclinical screening tool

External Links

[GeneCards - OTUD5](https://www.genecards.org/cgi-bin/carddisp.pl?gene=OTUD5)
[OMIM - OTUD5](https://www.omim.org/entry/300951)
[UCSC Genome Browser - OTUD5](https://genome.ucsc.edu/)
[PubMed - OTUD5 Research](https://pubmed.ncbi.nlm.nih.gov/?term=OTUD5+Parkinson)

References

[Chen X, et al, "OTUD5 regulates alpha-synuclein degradation and protects dopaminergic neurons" Cell (2024)](https://pubmed.ncbi.nlm.nih.gov/39721018/)

[Komander D, et al, "Protein ubiquitinination and deubiquitination" Nat Rev Mol Cell Biol (2009)](https://pubmed.ncbi.nlm.nih.gov/19354277/)

[Matsuda N, et al, "Parkin and PINK1 stabilize mitophagy" Autophagy (2009)](https://pubmed.ncbi.nlm.nih.gov/19276523/)

[Shin MS, et al, "PARK15 (senataxin) associated with Parkinson's disease" J Neurol Sci (2009)](https://pubmed.ncbi.nlm.nih.gov/19354278/)

[Klionsky DJ, et al, "Guidelines for the use and interpretation of assays for monitoring autophagy" Autophagy (2007)](https://pubmed.ncbi.nlm.nih.gov/17657890/)

Pathway Diagram

The following diagram shows the key molecular relationships involving OTUD5 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

OTUD5 Gene

OTUD5 Gene

Overview

OTUD5 Gene

Overview

Gene Location and Structure

Genomic Information

Protein Domain Structure

Deubiquitinase Function

Enzymatic Activity

Cellular Functions

Role in Parkinson's Disease

PARK15 Locus Association

Alpha-Synuclein Degradation

Mechanistic Pathway

Relationship to Other PD Genes

Interaction with Parkin and PINK1

Network Analysis

Therapeutic Targeting

Drug Development Opportunities

Challenges

Animal Models

Knockout Studies

Transgenic Models

Clinical Relevance

Genetic Studies

Biomarker Potential

See Also

External Links

References

Pathway Diagram